Category Archives: Regenerative Medicine

Learn how a new imaging center in South Korea is working to overcome existing experimental limitations with hopes to improve quality of life for patients

SelectScience talks with Eunsoo Lee, Director of Research Support at Ewha Womans University Fluorescence Core Imaging Center, about its work on fine-tuning methods to studythe microenvironment of cancer cells as well as tissue-specific cell differentiation. Here, Lee highlights the teams focus on designing and supporting experiments that require cooperative research and reveals a key technology underpinning its work.

Our center is still new, having opened just last month. It provides a variety of imaging systems to support the observation of cellular activity/the proteins and morphology of tissue samples. There is a research scientist in charge of each device to offer analytical services. I work on designing and supporting research experiments that require joint/cooperative research.

We are currently involved in research about the regulation of the microenvironment of cancer cells, as well as studying the regulation of reactive oxygen species (ROS) by organelles to determine the role and mechanisms of ROS. My personal research is to investigate the effects of tissue-specific extracellular matrix proteins on cell differentiation.

We are developing new experimental methods to control the microenvironment or control the levels of ROS freely, with the goal of further subdividing and fine-tuning them into organelle- and tissue-specific methods. For cell differentiation experiments using extracellular matrix proteins, we have developed a new method to secure tissue-specific extracellular matrix proteins and are looking to determine whether culturing stem cells in these proteins cause them to differentiate into the respective tissues cells. In this way, we try to overcome the existing experimental limitations by developing new techniques optimized for our research.

We frequently use both the LUNA-FL Dual Fluorescence Cell Counter and X-CLARITY Tissue Clearing System from Logos Biosystems - we keep the LUNA-FL where we culture our stem cells, and it is used for the qualitative and quantitative analysis of cells at each passage.

Ewha Woman's University Fluorescence Core Imaging Center

When studying the differentiation of stem cells according to their location in the brain, we have to isolate six regions of the brain and extract stem cells from each region. When using the traditional method to count cells, it is not only time consuming, but cell quality also slowly deteriorates over time. Using the LUNA-FL makes it possible to get stem cell counts from all six regions quickly while checking cell quality at the same time. Because of this, we can use a similar standard of cells every time, making our experiments more reliable.

Yes, Logos Biosystems products are generally designed with customers in mind and have the advantage of being very easy to use and fast. When it comes to the LUNA-FL, it is especially convenient that, after it counts the cells, there is a dilution calculator for subsequent experiments, and live/dead ratios that need to be recorded can be reviewed directly on the LUNA-FL. Lastly, I think most consumers would choose a product with an attractive design when considering similarly priced devices.

Early next year, Logos Biosystems will launch the newest member of the LUNA family, designed to build on the success of its predecessors: the LUNA-FX7 Automated Cell Counter.

As my research is mainly focused on using tissue scaffolds to study recellularization and tissue-specific cell differentiation, I am hopeful about this ultimately leading to the development of implants that can be used for patients. The development of tailored, purpose-specific functional scaffolds would be a huge contribution to improving patient quality of life in the field of regenerative medicine.

Do you use Logos Biosystems products in your lab? Write a review today for your chance to win a $400 Amazon gift card>>

Continue reading here:
Regenerative medicine technique development and the importance of cooperative research - SelectScience

Liming Wang,1,* Shigao Huang,2,* Shimei Li,1 Ming Li,1 Jun Shi,1 Wen Bai,1 Qianyun Wang,1 Libo Zheng,3 Yongjun Liu3

1Cell Therapy Center, 986 Hospital of Peoples Liberation Army Air Force, Xian, Shaanxi, Peoples Republic of China; 2Cancer Center, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macao SAR, Peoples Republic of China; 3Stem Cell Biology and Regenerative Medicine Institution, Yi-Chuang Institute of Bio-Industry, Beijing, Peoples Republic of China

*These authors contributed equally to this work

Correspondence: Shigao HuangCancer Center, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Room 3013, Building N-22, Taipa, Macau, Peoples Republic of ChinaEmail huangshigao2010@aliyun.comYongjun LiuStem Cell Biology and Regenerative Medicine Institution, Yi-Chuang Institute of Bio-Industry, No. 35, Jinghai 3 Road Economic-Technological Development Area, Beijing, Peoples Republic of ChinaEmail andyliuliu2001@aliyun.com

Background: The traditional anti-inflammation disease-modifying anti-rheumatic drugs (DMARDs) have limited therapeutic effects in rheumatoid arthritis (RA) patients. We previously reported the safety and efficacy of umbilical cord mesenchymal stem cell (UC-MSC) treatment in RA patients that were observed for up to 8 months after UC-MSC infusion. The aim of this study is to assess the long-term efficacy and safety of UC-MSC along with DMARDs for the treatment of RA.Methods: 64 RA patients aged 1864 years were recruited in the study. During the treatment, patients were treated with 40 mL UC-MSC suspension product (2 107 cells/20 mL) via intravenous injection immediately after the infusion of 100 mL saline. The serological markers tests were used to assess safety and the 28-joint disease activity score (DAS28) and the Health Assessment Questionnaire (HAQ) to assess efficacy.Results: 1 year and 3 years after UC-MSC cells treatment, the blood routine, liver and kidney function and immunoglobulin examination showed no abnormalities, which were all in the normal range. The ESR, CRP, RF of 1 year and 3 years after treatment and anti-CCP of 3 years after treatment were detected to be lower than that of pretreatment, which showed significant change (P < 0.05). Health index (HAQ) and joint function index (DAS28) decreased 1 year and 3 years after treatment than before treatment (P < 0.05).Conclusion: UC-MSC cells plus DMARDs therapy can be a safe, effective and feasible therapeutic option for RA patients.

Keywords: rheumatoid arthritis, umbilical cord mesenchymal stem cell, cell therapy

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Read more here:
Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy fo | DDDT - Dove Medical Press

December 19, 2019 - SACRAMENTO, CA- Secretary of State Alex Padilla announced that the proponent of a new initiative was cleared to begin collecting petition signatures.

The Attorney General prepares the legal title and summary that is required to appear on initiative petitions. When the official language is complete, the Attorney General forwards it to the proponent and to the Secretary of State, and the initiative may be circulated for signatures. The Secretary of State then provides calendar deadlines to the proponent and to county elections officials. The Attorney Generals official title and summary for the measure is as follows:

AUTHORIZES BONDS TO CONTINUE FUNDING STEM CELL AND OTHER MEDICAL RESEARCH. INITIATIVE STATUTE.Authorizes $5.5 billion in state general obligation bonds to fund grants from the California Institute of Regenerative Medicine to educational, non-profit, and private entities for: (1) stem cell and other medical research, therapy development, and therapy delivery; (2) medical training; and (3) construction of research facilities. Dedicates $1.5 billion to fund research and therapy for Alzheimers, Parkinsons, stroke, epilepsy, and other brain and central nervous system diseases and conditions. Limits bond issuance to $540 million annually. Appropriates money from General Fund to repay bond debt, but postpones repayment for first five years. Summary of estimate by Legislative Analyst and Director of Finance of fiscal impact on state and local governments:State costs of $7.8 billion to pay off principal ($5.5 billion) and interest ($2.3 billion) on the bonds. Associated average annual debt payments of about $310 million for 25 years. The costs could be higher or lower than these estimates depending on factors such as the interest rate and the period of time over which the bonds are repaid. The state General Fund would pay most of the costs, with a relatively small amount of interest repaid by bond proceeds.(19-0022A1.)

The Secretary of States tracking number for this measure is 1880 and the Attorney General's tracking number is 19-0022.

The proponent of the measure, Robert N. Klein, must collect signatures of 623,212 registered voters (five percent of the total votes cast for Governor in the November 2018 general election) in order to qualify it for the ballot. The proponent has 180 days to circulate petitions for the measure, meaning the signatures must be submitted to county elections officials no later than June 15, 2020*. The proponent can be reached c/o James C. Harrison of Remcho, Johansen & Purcell, LLP at (510) 346-6203. The address for Remcho, Johansen & Purcell, LLP is 1901 Harrison Street, Suite 1550, Oakland, CA 94612.

*Date adjusted for official deadline, which falls on a Sunday (Elec. Code 15)Source: CA. SOS

Go here to read the rest:
California Proposed Initiative Enters Circulation: Authorizes Bonds to Continue Funding Stem Cell and Other Medical Research - Sierra Sun Times

Serving alongside great men has been both an honor and privilege," said Bathurst "This role, the founders faith and passion, and the mission to continue to serve, are why I knew this team was ideal. Im very humbled to be a part of Time For A Hero to continue in service of our warriors."

SAN DIEGO (PRWEB) December 19, 2019

Retiring SEAL Commander and head of SOCOM Human Performance, Ty Bathurst, has been named Executive Director of Time for a Hero, a non-profit veterans organization dedicated to providing cost-free regenerative medicine treatments for Special Operations Forces.

I started Time for a Hero to help our nations greatest warriors get the world-class medical care they deserve, said Gregg Phillips, founder of Time for a Hero. These heroes come home from combat and suffer from wounds you cant see, like traumatic brain injuries and chronic pain. The only options theyre given are surgery, counseling, and a steady diet of pain meds. It shouldnt be that way. Stem cell therapy, hyperbaric oxygen treatments, nutritional and hormonal supplementation- these are regenerative therapies that have the potential to heal, but these treatments arent supported by the VA or covered by insurance. Thats why were doing what were doing. Its a travesty to deny our heroes the medical advancements that could restore their lives.

Ty Bathurst is the perfect fit to reach into the broader Special Operations Community and bring these much needed treatments to a community of warriors in need. His personal experience, passion and drive will continue to serve the Special Operations Community for years to come and we are excited to leverage his talents," remarked Phillips.

Serving alongside great men has been both an honor and privilege," said Bathurst "This role, the founders faith and passion, and the mission to continue to serve, are why I knew this team was ideal. Im very humbled to be a part of Time For A Hero to continue in service of our warriors."

Ty served multiple combat tours in Iraq and Afghanistan and worked extensively in South America, Europe and the Pacific. He earned the Bronze Star with V for Valor, a Purple Heart and several other awards and has been held aloft by a faithful bride of 22 years, three great children and all of Gods grace.

Time for a Hero (T4H), is a San Diego based 501c3 non-profit organization. Its mission is to save the lives of Special Operations Forces veterans by providing life-saving regenerative medical therapies to treat traumatic brain injuries sustained in combat, giving veterans and their families hope for a pain-free, drug-free life. For more information, please visit http://www.timeforahero.org.

Share article on social media or email:

Link:
Ty Bathurst, Former Navy SEAL Commander and Head of SOCOM Human Performance, Selected to Lead 'Time for a Hero' - PR Web

It has long been understood, and by cultures too various to list, that salamanders have something of the supernatural about them.

Their name is thought to derive from an ancient Persian vocable meaning 'fire within', and for at least 2,000 years they were believed to be impervious to flames, or even capable of extinguishing them on contact. Aristotle recorded this exceptional characteristic, as did Leonardo da Vinci. The Talmud advises that smearing salamander blood on your skin will confer inflammability. Not so. But the intuition that salamanders possess fantastical powers is not unfounded.

Like earthbound immortals, salamanders regenerate. If you cut off a salamander's tail, or its arm, or its leg, or portions of any of these, it will not form a stump or a scar but will instead replace the lost appendage with a perfect new one, an intricacy of muscle, nerve, bone and the rest. It will sprout like a sapling. Science has been chopping up salamanders for more than 200 years with the aim of simply understanding the mechanics of their marvels, but more recently with the additional aim of someday replicating those marvels in ourselves. Might salamanders be the great hope of regenerative medicine?

The salamander in which regeneration is most often studied is an odd and endearingly unattractive Mexican species known as the axolotl. In addition to its limbs and extremities, the axolotl is known to regrow its lower jaw, its retinae, ovaries, kidneys, heart, rudimentary lungs, spinal cord, and large chunks of its brain. It heals all sorts of wounds without scarring. The axolotl also integrates the body parts of its fellows as if they were its own, without the usual immune response, and this peculiar trait has facilitated some of the more grotesque disfigurements it's endured in the name of science. In experiments after the Second World War, East German scientists grafted small axolotls crosswise through the backs of larger ones. The animals' circulatory systems came to be linked, and the researchers hailed the conjoined mutants as triumphs of collectivism. While the axolotl can rebound from almost any bodily humiliation, it seems that humankind is proving too much for it: we have all but destroyed its natural habitat, and, outside of laboratory aquaria, it is nearly extinct.

In its most common form, which scientists call the white mutant, the axolotl resembles what the translucid foetus of a cross between an otter and a shortfin eel might look like. On the internet, it is celebrated for its anthropoid smile; in Mexico, where the Aztecs once hailed as it as a godly incarnation, it is an insult to say that someone looks like one. Behind its blunt and flattened head extends a distended torso resolving into a long, ichthyic tail. The axolotl can grow to nearly a foot in length; four tiny legs dangle off its body like evolutionary afterthoughts. It wears a collar of what seem to be red feathers behind each cheek, and these ciliated gill stalks float and tremble and gently splay in the water, like the plumage in a burlesque fan. They grow back if you cut them off, too. Precisely how the animal accomplishes this, or any of its feats of regrowth, is not well understood.

Like the axolotl, our evolutionary forebears seem to have been regenerators, and human children can in fact still regrow the tips of their fingers above the final joint, but that's the only complex regeneration we're known to do. We are, instead, a species that scars. Why our lineage lost its regenerative birthright is unclear. From our present evolutionary vantage point, however, it might be nice to get back what we lost. Amputees could recover their limbs; paralytics could walk; degeneration and decline of all sorts might be reversed.

Last year, after a long effort by an international consortium, the axolotl genome 10 times the length of the human genome was finally sequenced. In early 2019, it was mapped onto chromosomes by a team at the University of Kentucky. (It is, for the moment, the longest genome ever sequenced by far.) Jessica Whited, who heads an axolotl lab at Harvard Medical School, told me that, for those who hope to someday make regeneration available to human medicine, the axolotl is a perfect instruction manual. Its language simply needs decoding.

Regeneration is not, however, the axolotl's only biological extravagance, or prime mystery. Another puzzle of the axolotl concerned what it was. Most salamanders begin their lives as aquatic larvae, like tadpoles, before metamorphosing into terrestrial adults, but the axolotl seems to be a lifelong adolescent, the so-called 'Peter Pan of salamanders', remaining in its larval stage even as it arrives at sexual maturity. This retention of juvenile traits, a phenomenon known as neoteny, perplexed taxonomists, and for decades they debated whether it ought to be considered a species of its own or merely the larval form of the common tiger salamander. Confoundingly, on occasion the axolotl could be goaded (under what conditions remains unclear) into a final transformation, absorbing its gills and fins, and walking out of the water. In biological terms, the scale of this change is akin to a middle-aged human one day broadening her shoulders, lurching forward on her hands and loping off to the jungle to be a gorilla. In France, the Grand Dictionnaire Universel du XIXe sicle (1866) declared the axolotl 'the most imperfect, the most degraded of all the amphibians': a fallen creature, but also one that could accede, as if by grace, to a higher state of being.

Humans are attuned to this sort of qualified possibility. In 1920, the British biologist Julian Huxley found that he could cause axolotls to metamorphose by feeding them bits of sheep thyroid. The Daily Mail declared that Huxley had discovered 'The Elixir of Life'. Huxley's younger brother, the writer Aldous, adopted the axolotl as a metaphor for mankind, its peculiar neoteny an emblem of our incompletion, our frustrated potentiality. A number of his literary contemporaries became neoteny-boosters. Gerald Heard, the philosophising scholar, maintained in 1941 that the survival of mankind would depend upon individuals 'who manage to retain, with full mental stature, the radical originality and freshness of a vigorous child'; John Dewey and Timothy Leary held similar views. More recently, the Mexican sociologist Roger Bartra has proposed the axolotl, in its neotenous indeterminacy, as a symbol of his country's national character.

If the axolotl mirrors us so nicely, it's fitting that we, too, are neotenous. Our flat faces, small noses, hairless bodies and upright postures are all features of infancy in our evolutionary cousins and forebears. We also spend more of our lives in a juvenile state than any other primate. Our brains grow rapidly for a longer period, and are consequently larger; our childhoods are greatly extended, providing occasion for the lengthy training of those brains. We also maintain throughout our lives a 'remarkable persistent juvenile characteristic of investigative curiosity', in the words of the zoologist Konrad Lorenz. 'The constitutive character of man,' Lorenz wrote in 1971, 'is a neotenous phenomenon.'

Some affinity seems to have drawn us to the salamander since well before we fantasised in a serious way of regrowing our bodies how the salamander regrows its own. Perhaps this is what spurred the ancients and the Aztecs to ennoble the animals through mythology. Nowhere has the intuition of kinship been rendered more plainly, though, than in the Argentinian surrealist Julio Cortzar's short story 'Axolotl' (1952). Cortzar writes of one man's quiet obsession with the animals, whom he visits every day at an aquarium. 'After the first minute I knew that we were linked,' the man says, 'that something infinitely lost and distant kept pulling us together.' He watches through the glass tank until, one day, almost imperceptibly, he finds himself suspended in the water beside the creatures, transmuted into one of them, peering out at his former human soma peering in. 'Only one thing was strange: to go on thinking as usual,' the erstwhile man says, 'to know.'

This article was originally published at Aeon and has been republished under Creative Commons. Read the original article.

From Your Site Articles

Related Articles Around the Web

Read the original post:
Can the axolotl teach us to regenerate? - Big Think

SmartTRAK recently redesigned SmartTRAK.com to prioritize key information for various functional groups as their customer base continues to expand

BioMedGPS, the developer of SmartTRAK Business Intelligence, is excited to announce the launch of their new website, Smarttrak.com. SmartTRAK offers a suite of advisory services for the life sciences industry including real-time online business intelligence and custom consulting.

The new SmartTRAK.com features a clean uncluttered design, improved functionality and enhanced custom content. It allows for medical device professionals to self-identify and learn how SmartTRAKs services, data, and industry insights help meet their specific professional needs. Visitors can learn how SmartTRAK can help streamline their workflow, saving them time while keeping them ahead of the market.

Marketing Technology News: Users Reveal Top Five SMM Vendors of 2019 for User Satisfaction Through SoftwareReviews

The newly launched site also spotlights our industry analysts all who are experts in their fields with years experience working for some of the biggest players in the industry. Visitors can sample articles, analyses and white papers put out by SmartTRAKs team.

Users can also view SmartTRAKs offering by market coverage including orthopedics, wound care, regenerative medicine and neuro therapies. Visitors can quickly pinpoint what coverage they would need and also quickly assess any future needs.

Marketing Technology News: MindTouch Enhances Salesforce Integration for an Improved Customer and Agent Experience

The new site, content and improved functionality speak directly to the needs of our customers. We believe that this new website will allow our visitors to have a very informative experience as we continue to grow, states Sharon OReilly, CEO, and President of BioMedGPS.

Medical device manufacturers who have business intelligence needs are encouraged to reach out to SmartTRAK to learn how SmartTRAK can support their teams.

Marketing Technology News: Ameriprise Financials New Customer Relationship Management System Helps Advisors Deliver Best-in-Class Service

See more here:
SmartTRAK Launches New Website that Speaks Directly to Customer Needs - MarTech Series

NEWPORT NEWS, Va.,Dec. 18, 2019/PRNewswire/ Orthopaedic and Spine Center announced Dr.Jeffrey Carlson, Orthopaedic Spine Surgeon, became the first surgeon in Central andEastern Virginiaarea to implant the M6-Cartificial cervical disc. The outpatient surgery was performed on a 53 year old female at Bon Secours/Mercy Health Mary Immaculate Hospital inNewport News, VirginiaonNovember 20, 2019.

The patient reported symptoms of severe neck pain which radiated to both shoulders after a motor vehicle accident. After she failed to respond to conservative treatment, an MRI was ordered revealing severe spinal stenosis and spinal cord abutment at level C3-4 caused by a herniated disc. In consultation with Dr. Carlson, the patient made the decision to have cervical disc arthroplasty, using the Orthofix M6-C artificial cervical disc.

Ive been waiting for the right patient with the appropriate diagnosis to employ the M6-C disc, said Carlson. The technology used in this procedure facilitates a speedy recovery with minimal limitations and a great outcome, so that my patient can get back to her active life. She just had her two week post-surgical follow-up appointment her recovery is going very well and she feels much relief from the severe pain she once experienced.

The M6-C disc received U.S. Food and Drug Approval in February 2019.It was designed to closely mimic the anatomic structure of a natural disc as well as provide an effective alternative to a spinal fusion. By allowing the spine to move naturally, the M6-C artificial disc potentially minimizes stress to adjacent discs and other vertebral structures.

AboutJeffrey R. Carlson, M.D.Dr.Jeffrey Carlsonhas been a part of Orthopaedic & Spine Center since 1999 and serves as the President and Managing Partner. He is a board-certified, fellowship-trained orthopaedic surgeon who focuses on the treatment of injuries and disorders of the spine.

About Orthopaedic & Spine CenterOrthopaedic & Spine Center (OSC) is staffed by outstanding medical professionals who strive to provide the very best orthopaedic and interventional pain management care available anywhere. Our Center includes a comfortable, state-of-the-art medical facility, pleasant and well-trained personnel, physicians trained in the most advanced orthopaedic treatments, interventional pain management procedures, regenerative medicine, using stem cell and platelet therapies and a dedication to old-fashioned patient care.

SOURCE Orthopaedic & Spine Center

osc-ortho.com

See the rest here:
Orthopaedic Surgeon, Dr. Jeffrey Carlson, first in Central and Eastern Virginia to implant the M6-C Artificial Cervical Disc - OrthoSpineNews

The International Society for Stem Cell Application (ISSCA), in collaboration with SISDET, held a highly successful three-day medical conference on the University of Miami campus on October 24-26. The conference featured a host of international experts in regenerative medicine and introduced new standards in regenerative medicine protocols to those in attendance. The Miami conference is part of the ISSCAs growing commitment to increasing the awareness and practice of regenerative medicine across the globe in an effort to help alleviate suffering for those diagnosed with degenerative diseases.

Around 200 physicians, scientists, and researchers interested in regenerative medicine traveled to the University of Miami campus for the event. The conference focused on providing attendees with information on todays most successful stem cells treatment protocols and the latest advances in regenerative medicine. Attendees heard from more than 20 expert speakers within the stem cells field, with lecturers from Europe, the US, and Latin America on the conference agenda.

This three-day event included recognized keynote speakers, as well as aspiring young physicians discussing the latest advances in stem cell biology in an informal and collaborative setting, said Benito Novas, Vice President of Public Relations for ISSCA. Our goal with all of our events is to strengthen the cooperative and dynamic spirit in this research area. We would also like to thank the University of Miami for hosting this event, as it was a great honor partnering with such a prestigious university.

ISSCA is a global leader in stem cells research, applications, and education, partnering with major global institutions and locations worldwide to host its independent medical congresses. To learn more about the ISSCA and its all of its past and upcoming events, visit http://www.issca.us

About International Society for Stem Cells Applications

The International Society for Stem Cells Applications (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

ISSCA bridges the gaps between scientists and practitioners in Regenerative Medicine. Their code of ethics emphasizes principles of morals and ethical conducts.

At ISSCA, their vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification. ISSCA serves its members through advancements made to the specialty of regenerative medicine. They aim to encourage more physicians to practice regenerativemedicine and make it available to benefit patients both nationally and globally.

For more information, please visit https://www.issca.us/ or send an email to info@stemcellsgroup.com

Visit link:
ISSCA Conference at University of Miami Attracts Regenerative Medicine Experts and Physicians from across the Globe - PRUnderground

Have you wondered about new and innovative pain treatment processes that could change your quality of life?

Join us Monday, December 16, 7PM at the Woodbridge Main Library as Manisha Chahal, MD of Edison-Metuchen Orthopaedic Group discusses Regenerative Medicine to Treat Pain. Dr. Chahal will walk us through the promising results of regenerative medicine with a focus on platelet rich plasma and stem cells. She will explain how this process works and the evidence to support this cutting edge science. Dr. Chahal will also describe the best practices to go about and the indications to look out for. She will disclose how to avoid misleading providers and illegitimate products.

About Dr. Manisha Chahal, MD

Dr. Manisha Chahal is a board certified Interventional Pain Management Physician who specializes in minimally invasive procedures for pain.

Dr. Chahal treats the following conditions: headache, lower back pain, joint pain, neck pain, CRPS, postherpetic neuralgia, abdominal wall pain, pelvic pain, coccydynia, and sciatica.

Additionally, Dr. Chahal also performs the following procedures: spinal cord stimulators, regenerative medicine (PRP & stem cell injections), Botox for migraines, cervical epidural steroid injection, lumbar translaminar or transforaminal epidural steroid injections, cervical and lumbar facet rhizotomy, discograms, nerve blocks (ultrasound & C-arm guided), knee genicular blocks & rhizotomy, joint injections, trigger point injections, and qutenza treatment (chemical rhizotomy) for PHN pain.

She received her medical degree from Howard University where she was awarded a Trustee Scholarship for academic achievement. She completed her anesthesia residency training at Beth Israel Deaconess Medical Center (Harvard) in Boston. Dr. Chahal did her Pain Management Fellowship at New York Presbyterian/ Weill Cornell Medical Center in NYC. She is board certified by the American Board of Anesthesiology for both anesthesia and pain medicine.

She treats a wide variety of pain diagnoses and has expertise in many procedures including spinal cord stimulators, transforaminal epidural injections, rhizotomies, ultrasound guided nerve blocks, regenerative treatments and botox.

Dr. Chahal's philosophy is use every pain management option available to help patients ease their pain and "get their life back."

The Woodbridge Main Library is located at 1 George Frederick Plaza in Woodbridge, NJ. If you have any questions or need any further information please contact us at 732-634-4450 or visit our website -www.woodbrigelibrary.org.

View original post here:
Learn How You Can Treat Your Pain with Regenerative Medicine! - Patch.com

Mens Wellness

First Place: Thrive Regenerative Medicine

1835 W. Chandler Blvd., Chandler

480-257-5022, thrivemed.com

Dr. Dan Larke of Thrive Regenerative Medicine specializes in mens sexual wellness, testosterone therapy, Peyronies disease and various other mens health issues.

He is the only Southeast Valley provider of GAINSWave, a non-invasive, proven procedure that uses low-intensity shock waves to reverse the effects of erectile dysfunction caused by low blood flow.

His goal is to help men fully understand the underlying causes of health problems and find a treatment plan that helps patients reach their full health potential in all areas of life.

Dr. Larke also builds long-term relationships with his patients to become a trusted advisor for their health.

Second Place:Valley Mens Health

3100 W. Ray Road, Chandler

480-999-5621

Third Place: Vital4Men

655 S. Dobson Road, Chandler

480-223-1312, vital4men.com/locations/chandler

More:
Thrive Regenerative Medicine | Medical And Dental - East Valley Tribune